scispace - formally typeset
E

Elio Riboli

Researcher at Imperial College London

Publications -  1180
Citations -  127554

Elio Riboli is an academic researcher from Imperial College London. The author has contributed to research in topics: European Prospective Investigation into Cancer and Nutrition & Cancer. The author has an hindex of 158, co-authored 1136 publications receiving 110499 citations. Previous affiliations of Elio Riboli include Institute of Cancer Research & German Cancer Research Center.

Papers
More filters
Journal ArticleDOI

Alcohol and lung cancer risk among never smokers: A pooled analysis from the international lung cancer consortium and the SYNERGY study

Gordon Fehringer, +60 more
TL;DR: The results indicate that alcohol consumption is inversely associated with lung cancer risk, particularly among subjects with low to moderate consumption levels, and among wine and liquor drinkers, but not beer drinkers.
Book ChapterDOI

The European Prospective Investigation into Cancer and Nutrition biobank.

TL;DR: This chapter describes the building up of the EPIC central biobank and the mechanisms that have been developed to manage the access to specimens by a large number of different users.
Journal ArticleDOI

An epidemiological model for prediction of endometrial cancer risk in Europe.

TL;DR: A step-wise model selection process was used to select confirmed predictive epidemiologic risk factors and a large-scale cohort-consortium approach would be needed to assess and adjust for population variation.
Journal ArticleDOI

Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.

TL;DR: Common genetic variation in the GH synthesis pathway, as measured by single nucleotide polymorphisms selected in the present study, is not a major determinant of IGF-I and IGFBP-3 circulating levels, and it does not play a major role in altering breast cancer risk.